Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src
- PMID: 1710290
- PMCID: PMC241411
- DOI: 10.1128/JVI.65.7.3804-3812.1991
Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src
Abstract
The molecular mechanism by which retroviral Gag proteins are directed to the plasma membrane for the formation of particles (budding) is unknown, but it is widely believed that the MA domain, located at the amino terminus, plays a critical role. Consistent with this idea, we found that small deletions in this segment of the Rous sarcoma virus Gag protein completely blocked particle formation. The mutant proteins appear to have suffered only localized structural damage since they could be rescued (i.e., packaged into particles) when coexpressed with Gag proteins that are competent for particle formation. To our surprise, the effects of the MA deletions could be completely suppressed by fusing as few as seven residues of the myristylated amino terminus of the oncoprotein p60src to the beginning of the mutant Gag proteins. Particles produced by the chimeras were of the same density as the wild type. Two myristylated peptides having sequences distinct from that of p60src were entirely unable to suppress MA deletions, indicating that myristate alone is not a sufficient membrane targeting signal. We hypothesize that the amino terminus of p60src suppresses the effects of MA deletions by diverting the Rous sarcoma virus Gag protein from its normal site of assembly to the Src receptor for particle formation.
Similar articles
-
Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.J Virol. 1998 Nov;72(11):9034-44. doi: 10.1128/JVI.72.11.9034-9044.1998. J Virol. 1998. PMID: 9765448 Free PMC article.
-
Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.J Virol. 1993 Nov;67(11):6487-98. doi: 10.1128/JVI.67.11.6487-6498.1993. J Virol. 1993. PMID: 8411352 Free PMC article.
-
Processing of p60v-src to its myristylated membrane-bound form.Mol Cell Biol. 1985 Oct;5(10):2781-8. doi: 10.1128/mcb.5.10.2781-2788.1985. Mol Cell Biol. 1985. PMID: 3016513 Free PMC article.
-
Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.J Virol. 1993 Sep;67(9):5550-61. doi: 10.1128/JVI.67.9.5550-5561.1993. J Virol. 1993. PMID: 8394460 Free PMC article.
-
Transformation by p60src with altered N-terminal sequences.Princess Takamatsu Symp. 1986;17:233-40. Princess Takamatsu Symp. 1986. PMID: 2843496 Review.
Cited by
-
The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle.J Virol. 1992 Sep;66(9):5667-70. doi: 10.1128/JVI.66.9.5667-5670.1992. J Virol. 1992. PMID: 1501299 Free PMC article.
-
Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.J Virol. 2011 Oct;85(20):10851-60. doi: 10.1128/JVI.00760-11. Epub 2011 Aug 3. J Virol. 2011. PMID: 21813603 Free PMC article.
-
Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.J Virol. 1995 Apr;69(4):2366-77. doi: 10.1128/JVI.69.4.2366-2377.1995. J Virol. 1995. PMID: 7884882 Free PMC article.
-
Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.J Virol. 1998 Nov;72(11):9034-44. doi: 10.1128/JVI.72.11.9034-9044.1998. J Virol. 1998. PMID: 9765448 Free PMC article.
-
Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.J Virol. 1993 Dec;67(12):7067-76. doi: 10.1128/JVI.67.12.7067-7076.1993. J Virol. 1993. PMID: 7693966 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous